Table 1. The frequency of AML1 mutations... | American Society of Hematology

Table 1.

The frequency of AML1 mutations in the specific subtype of MDS

Subtypes of MDS	Previous studies				This study
	Osato⁸ (1999)	Song¹¹^* (1999)	Preudhomme¹⁰ (2000)	Imai⁹ (2000)	Total	A-bomb
	Osato⁸ (1999)	Song¹¹^* (1999)	Preudhomme¹⁰ (2000)	Imai⁹ (2000)	Total	+	−
RA	0/0	—	0/13	0/18	1/24	1/4	0/20
RARS	0/0	—	0/4	0/0	0/1	0/0	0/1
RAEB	0/0	—	0/23	0/2	0/21	0/1	0/20
RAEBt	0/0	—	0/27	0/5	6/24	4/7	2/17
CMMoL	0/0	—	0/27	1/2	0/4	0/0	0/4
MDS Leukemia	0/6	—	0/0	1/10	1/13	1/1	0/12
Total (%)	0/6 (0)	1/14 (7.1)	0/94 (0)	2/37 (5.4)	8/87 (9.2)	6/13^† (46)	2/74^† (2.7)

Subtypes of MDS	Previous studies				This study
	Osato⁸ (1999)	Song¹¹^* (1999)	Preudhomme¹⁰ (2000)	Imai⁹ (2000)	Total	A-bomb
	Osato⁸ (1999)	Song¹¹^* (1999)	Preudhomme¹⁰ (2000)	Imai⁹ (2000)	Total	+	−
RA	0/0	—	0/13	0/18	1/24	1/4	0/20
RARS	0/0	—	0/4	0/0	0/1	0/0	0/1
RAEB	0/0	—	0/23	0/2	0/21	0/1	0/20
RAEBt	0/0	—	0/27	0/5	6/24	4/7	2/17
CMMoL	0/0	—	0/27	1/2	0/4	0/0	0/4
MDS Leukemia	0/6	—	0/0	1/10	1/13	1/1	0/12
Total (%)	0/6 (0)	1/14 (7.1)	0/94 (0)	2/37 (5.4)	8/87 (9.2)	6/13^† (46)	2/74^† (2.7)

RARS indicates refractory anemia with ringed sideroblasts; CMMoL, chronic myelomonocytic leukemia.

Subtypes not provided.

P < .0001.